Kunkel Lori Anne

Track

Insider profile

Kunkel Lori Anne's trades of Enliven Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Curis Inc (CRIS)
Transaction date
Planned sale
Price
1.05
Quantity 14,800 -40.0%
Value US$15,581
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-06
PlS Planned sale
87,830 -14.7%
326.64
US$3,600,936 		87,830 -14.7% 326.64 US$3,600,936
2026-07-08 2026-07-06
PlS Planned sale
73,108 -1.6%
467.65
US$4,815,778 		73,108 -1.6% 467.65 US$4,815,778
2026-06-09 2026-06-05
PlS Planned sale
46,121 +46.4%
69.39
US$2,942,895 		46,121 +46.4% 69.39 US$2,942,895
2026-06-09 2026-06-05
PlS Planned sale
1,867 -3.5%
35.36
US$66,012 		1,867 -3.5% 35.36 US$66,012
2026-06-09 2026-06-05
PlS Planned sale
7,779 -12.6%
34.28
US$266,659 		7,779 -12.6% 34.28 US$266,659
2026-06-05 2026-06-05
PrS Proposed sale
20,000
35.49
US$709,800 		20,000 35.49 US$709,800
2026-06-05 2026-06-05
PrS Proposed sale
20,000
35.49
US$709,800 		20,000 35.49 US$709,800
2019-01-25 2019-01-23
US Curis Inc (CRIS)
PlS Planned sale
14,800 -40.0%
1.05
US$15,581 		14,800 -40.0% 1.05 US$15,581